Lawrence McMillan

Sirius XM Poised to Profit from Muzak Bankruptcy

I agree with the concept of satellite radio, but these guys (XM/Sirius) are woeful at actually running a business. I have been a long-term XM subscriber and have paid ahead $300 or so. Now, I have a new car with a Sirius radio receiver in it. I can't transfer the money to a Sirius account. Nor can I use any of the additional equipment I had. I have to get new portable radios for the office, etc., or operate two separate accounts. Until they clear up things like this, this stock is going nowhere

Expect FDA Approval of AMAG Pharmaceutical's Feraheme

Also, SOMEONE is paying 1.20 for the July 40 put and/or 0.65 for the July 35 put, with the stock at 54.64.
The July 65 call is offered at 0.95.
There is a huge negative skew in the puts, so someone is worried about this upcoming event.

Expect FDA Approval of AMAG Pharmaceutical's Feraheme

As an options trader, it is interesting to note that the near-term straddles (put+call) are trading at about 10. There is no particular skew towards the calls, so it looks like the risk/reward is probably about +10/-10, although sometimes the "event" actually overshoots those parameters.